AW
IMVT icon

Alchemi Wealth’s Immunovant IMVT Stock Holding History

Alchemi Wealth’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Sell
46,500
-7,516
-14% -$229K 0.84% 29
2026
Q1 		$1.34M Sell
54,016
-2,560
-5% -$66.3K 0.74% 29
2025
Q4 		$1.44M Buy
+56,576
New +$1.26M 0.79% 25

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Alchemi Wealth's IMVT Position: Q2 2026 in Review

Alchemi Wealth reduced its Immunovant (IMVT) stake by 14% in Q2 2026, selling an estimated $229K and leaving 46,500 shares worth $1.79M. The position accounts for 0.84% of the portfolio, ranked #29.

Alchemi Wealth first reported a position in IMVT in Q4 2025 and has held it in 3 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Alchemi Wealth held 46,500 shares of Immunovant worth $1.79M as of Q2 2026.
  • Alchemi Wealth sold 7,516 Immunovant shares in Q2 2026, an estimated $229K.
  • Immunovant made up 0.84% of Alchemi Wealth's portfolio in Q2 2026, its #29 holding.
  • Alchemi Wealth first reported a position in Immunovant in Q4 2025 and has held it in 3 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Alchemi Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.